| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.097 | 0.5 |